"Dancing molecules," the promising new treatment for acute spinal cord injuries developed at Northwestern University, has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA).
"The new institute will advance the development of medical tools that empower the human body to heal, focusing on the regeneration or reconstruction of various tissues and organs."